Clinical Trial Update: Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP [NA]

View source ↗

Summary

Completed clinical trial evaluating ATP therapy in primary prevention ICD patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Death

Drugs mentioned

• Implantable cardioverter-defibrillator with antitachycardia pacing (ATP)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Sudden Cardiac Death | NA | Status: COMPLETED | Results posted: 2024-10-22